Sastasundar Ventures Ltd
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
- Market Cap ₹ 886 Cr.
- Current Price ₹ 279
- High / Low ₹ 383 / 205
- Stock P/E 24.5
- Book Value ₹ 211
- Dividend Yield 0.00 %
- ROCE -0.22 %
- ROE 5.05 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company's median sales growth is 37.1% of last 10 years
- Company's working capital requirements have reduced from 63.1 days to 38.7 days
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -1.12% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,111 | |
| 35 | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,167 | |
| Operating Profit | -4 | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -56 |
| OPM % | -15% | -19% | -31% | -15% | -8% | -15% | -13% | -2% | 62% | -10% | -2% | -5% |
| 0 | 2 | -0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -131 | |
| Interest | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 |
| Depreciation | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 |
| Profit before tax | -7 | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -193 |
| Tax % | -5% | -0% | -1% | 2% | 19% | 3% | -9% | 4% | 22% | -19% | -119% | -36% |
| -6 | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | |
| EPS in Rs | -2.03 | -4.68 | -11.51 | -9.00 | -3.73 | -11.81 | -12.19 | -3.27 | 197.05 | -22.70 | 2.79 | -28.66 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 23% |
| 3 Years: | -15% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 24% |
| 3 Years: | 44% |
| TTM: | 525% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 29% |
| 3 Years: | -2% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -2% |
| 3 Years: | -1% |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 238 | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 |
| 0 | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | |
| 39 | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 304 | |
| Total Liabilities | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 974 |
| 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | |
| CWIP | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 |
| Investments | 41 | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 |
| 151 | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 287 | |
| Total Assets | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 974 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36 | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 38 | -17 | |
| -42 | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 | |
| -3 | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | -0 | |
| Net Cash Flow | -10 | -1 | -0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | 2 | -19 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 169 | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 11 | 3 |
| Inventory Days | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 | |
| Days Payable | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 | |
| Cash Conversion Cycle | 169 | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 33 | 22 |
| Working Capital Days | 443 | 377 | 247 | 99 | 89 | 61 | 54 | 44 | 46 | 93 | 58 | 39 |
| ROCE % | -2% | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% | -3% | -0% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR) Regulations, 2015
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 Jun - Scheduled Q4 & FY25 earnings call on 12 June 2025 at 3:30 PM IST with analysts and investors.
- Announcement under Regulation 30 (LODR)-Investor Presentation 2 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Publication of Audited Financial Results for the quarter and financial year ended 31st March 2025 in the Newspapers
-
Disclosure Under Reg 30 Of SEBI LODR - Completion Of Transaction For Sale Of Stake Of Step Down Subsidiary
31 May - Completed sale of stake in Happymate Foods, ceasing it as step-down subsidiary on 30 May 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Jun 2025TranscriptNotesPPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
-
Oct 2024TranscriptNotesPPT
-
Jun 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
Mar 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Sep 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Mar 2022TranscriptNotesPPT
-
Dec 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
Business Overview:[1][2][3]
SSVL, a Core Investment Company (CIC), operates through multiple subsidiaries and offers a digital platform for pharmacy, wellness, and diagnostics, serving both B2B and B2C segments with person-centric healthcare solutions.